1. Changes in labor outcomes after implementing structured use of oxytocin augmentation with a 4-hour action line
- Author
-
Fride E. Austad, Torbjørn Moe Eggebø, and Janne Rossen
- Subjects
Labor, Obstetric ,030219 obstetrics & reproductive medicine ,Cesarean Section ,business.industry ,Postpartum Hemorrhage ,Obstetrics and Gynecology ,Prolonged labor ,Oxytocin ,Ten group classification system ,Labor management ,03 medical and health sciences ,0302 clinical medicine ,Action (philosophy) ,Pregnancy ,Oxytocics ,Pediatrics, Perinatology and Child Health ,Humans ,Medicine ,Female ,Operations management ,030212 general & internal medicine ,Line (text file) ,business ,medicine.drug - Abstract
Oxytocin augmentation is essential in labor management, but how to optimize its use is still debated. Joint international guidelines regarding prolonged labor and the use of oxytocin augmentation are still not available. Due to its potential harmful side effects, a decreased use of oxytocin is encouraged. We aimed to implement a structured protocol on the use of oxytocin augmentation and to observe changes in labor outcomes.The protocol was implemented at the Obstetric Department of Sørlandet Hospital, Kristiansand, Norway on 1 January 2012; therefore, data from the hospital were collected prospectively and compared for two time-period cohorts: the historic control cohort (2009-2010) and the study period cohort (2012-2013). The structured protocol instructs, and restricts, the birth attendants to diagnose prolonged labor, by protocol definition only, before commencing oxytocin infusion for augmentation. Nulliparous women with singleton, term deliveries (≥37 weeks), cephalic presentation, and spontaneous onset of labor (Ten-Group Classification System (TGCS) group 1) were included in the analysis. The main outcome was use of oxytocin augmentation.The study cohort and control cohort comprised 1103 (26.2%) and 1399 (33.1%) of all laboring women, respectively (Implementation of a protocol of structured use of oxytocin augmentation reduced the frequency, dosage, and duration of oxytocin without increasing the cesarean section rate in TGCS group 1.
- Published
- 2019